Term
|
Definition
blocks entrance of Choline into cholinergic nerve (inhibits synthesis of ACh) |
|
|
Term
|
Definition
|
|
Term
|
Definition
inhibits entry of dopamine into vesicle where NE synthesis occurs |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
ACh agonist. it activates bowel and bladder smooth muscle. Use is for postoperative and neurogenic ileus and urinary retention. |
|
|
Term
|
Definition
ACh agonists. they activate ciliary muscle of the eye (open angle), pupillary sphincter (narrow angle). Use for glaucoma. |
|
|
Term
|
Definition
reversibly binds to AChE. increases endogenous ACh. Use for postoperative and neurogenic ileus and urinary retention, myastenia gravis, reversal of neuromuscular junction blockade post-op |
|
|
Term
|
Definition
reversibly binds AChE, increases endogenous ACh and increases strength. Use for myasthenia gravis. |
|
|
Term
|
Definition
reversible inhibitor of AChE. increases endogenous ACh. use for DX of myasthenia gravis b/c it is so short acting |
|
|
Term
|
Definition
reversibly binds AChE, increases endogenous ACh. Use for glaucoma (crosses BBB -> CNS), and atropine OD |
|
|
Term
|
Definition
irreversibly binds to AChE. increases endogenous ACh. Use for glaucoma. |
|
|
Term
Cholinesterase inhibitor poisoning SX and TX |
|
Definition
DUMBBELSS - Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Excitation of skeletal muscle and CNS, Lacrimation, Sweating, and Salivation.
TX - Atropine plus pralidoxime (to regenerate active cholinesterase) |
|
|
Term
|
Definition
muscarinic antagonist. results in increased pupil dilation, cycloplegia, decreased airway secretions, decreased acid secretion in stomach, decreased gut motility, decreased urgency in cystitis. Blocks SLUD - salivation, lacrimation, urination, defecation. |
|
|
Term
|
Definition
increased body temperature, rapid pulse, dry mouth, dry and flushed skin, cycloplegia, constipation, disorientation. Side effects: "hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter." |
|
|
Term
atropine, homatropine, tropicamide use |
|
Definition
produce mydriasis and cycloplegia |
|
|
Term
|
Definition
muscarinic antagonist. used for Parkinson's disease |
|
|
Term
|
Definition
muscarinic antagonist. used for motion sickness |
|
|
Term
|
Definition
muscarinic antagonist. Used for asthma, COPD |
|
|
Term
|
Definition
nicotinic ACh receptor antagonist. Use - ganglionic blocker. used to prevent vagal reflex responses to changes in BP (eg - prevents reflex bradycardia caused by NE) |
|
|
Term
Alpha selective cardiovascular effects |
|
Definition
decreased HR due to reflex bradycardia, vasoconstriction causes increases in both systolic and diastolic BP. increased mean BP, no change in pulse pressure |
|
|
Term
Beta selective cardivascular effects |
|
Definition
increases HR and contractility. vasodilates skeletal muscle vessels. small decrease in systolic pressure, large decrease in diastolic pressure. decrease in mean BP and increased pulse pressure. |
|
|
Term
non-selective sympathomimetic cardiovascular effects |
|
Definition
increased contractility, increased stroke volume and cardiac output. increase in systolic BP, decreased diastolic BP. no change in mean BP, increased pulse pressure |
|
|
Term
|
Definition
alpha 1 and 2, beta 1 and 2 agonist.
Use - anaphylaxis, glaucoma (open angle), asthma, hypotension |
|
|
Term
|
Definition
alpha 1 and 2, beta 1 agonist. (alpha > beta)
Use - hypotension (but decrease in renal perfusion) |
|
|
Term
|
Definition
beta 1 and 2 agonist.
Use - AV block (rare) |
|
|
Term
|
Definition
D1 = D2 > beta > alpha agonist.
Use - shock (with increased renal perfusion), heart failure |
|
|
Term
|
Definition
beta 1 > beta 2 agonist.
Use - shock, heart failure |
|
|
Term
|
Definition
indirect general agonist, releases stored catecholamines.
Use - narcolepsy, obesity, ADD |
|
|
Term
|
Definition
indirect general agonist, releases stored catecholamines.
Use - nasal decongestion, urinary incontinence, hypotension |
|
|
Term
|
Definition
alpha 1 > alpha 2 agonist.
Use - pupil dilator, vasoconstriction, nasal decongestion |
|
|
Term
|
Definition
beta 2 > beta 1 agonist.
Use - asthma |
|
|
Term
|
Definition
indirect general agonist, uptake inhibitor.
It causes vasoconstiction and local anesthesia. |
|
|
Term
Clonidine, alpha-methyldopa |
|
Definition
centrally acting alpha agonist, decreased central adrenergic outflow.
Use - HTN especially with renal disease b/c it doesn't cause a decrease in blood flow to the kidney |
|
|
Term
non-selective alpha blockers |
|
Definition
phenoxybenzamine (irreversible), and phentolamine (reversible) |
|
|
Term
phenoxybenzamine and phentolamine use and toxicity |
|
Definition
Use - pheochromocytoma
Toxicity - orthostatic hypotension, reflex tachycardia |
|
|
Term
alpha 1 selective blockers (3) |
|
Definition
prazosin, terazosin, doxazosin |
|
|
Term
prazosin, terazosin, and doxazosin use and toxicity |
|
Definition
Use - HTN, urinary retention in BPH
Toxicity - 1st dose orthostatic hypotension, dizziness, headache |
|
|
Term
alpha 2 selective blocker |
|
Definition
|
|
Term
mirtazapine use and toxicity |
|
Definition
Use - depression
Toxicity - sedation, increased cholesterol, increased appetite |
|
|
Term
non-selective beta blockers (5) |
|
Definition
propranolol, timolol, pindolol, nadolol, and labetalol (also blocks alpha 1) |
|
|
Term
beta 1 selective blockers (5) |
|
Definition
A BEAM - Acebutolol, Betaxolol, Esmolol (short acting), Atenolol, Metoprolol |
|
|
Term
beta blocker effect on HTN |
|
Definition
decreased cardiac output, decreased renin secretion |
|
|
Term
beta blocker effect on angina pectoris |
|
Definition
decreased heart rate and contractility, resulting in decreased O2 consumption |
|
|
Term
beta blocker effect on MI |
|
Definition
|
|
Term
beta blocker effect on SVT |
|
Definition
propranolol and esmolol decrease AV conduction velocity |
|
|
Term
beta blocker effect on CHF |
|
Definition
|
|
Term
beta blocker effect on glaucoma |
|
Definition
timolol decreases secretion of aqueous humor |
|
|
Term
|
Definition
impotence, exacerbation of asthma, bradycardia, AV block, CHF, sedation, sleep alterations. Use with caution in diabetics |
|
|
Term
Epinephrine as a glaucoma drug |
|
Definition
MOA - increased outflow of aqueous humor.
SE - mydriasis, stinging, do not in closed-angle glaucoma |
|
|
Term
Brimonidine (alpha agonist) as a glaucoma drug |
|
Definition
MOA - decreased humor synthesis.
no pupillary or vision changes |
|
|
Term
Beta blockers as glaucoma drugs (timolol, betaxolol, careolol) |
|
Definition
decreased aqueous humor synthesis. no pupillary or vision changes |
|
|
Term
Acetazolamide as a glaucoma drug |
|
Definition
decreases aqueous humor secretion due to decreased HCO3. no pupillary or vision changes. |
|
|
Term
cholinomimetics as glaucoma drugs (pilocarpine, carbachol, physostigmine, echothiophate) |
|
Definition
increased outflow of aqueous humor; contract ciliary muscle and open trabecular meshwork. SE - miosis, cyclospasm |
|
|
Term
Latanoprost (a prostaglandin) as a glaucoma drug |
|
Definition
increases outflow of aqueous humor. SE - darkens color of iris. |
|
|